Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities

As the ninth leading cause of death globally, diabetes mellitus (DM) is considered to be the worst chronic metabolic disease requiring an enormous need for healthcare with over 578 million expected cases by 2023. Several recent findings have demonstrated that mediating the activity of carbohydrate-h...

Descripción completa

Detalles Bibliográficos
Autores principales: Khirallah, Salma M., Ramadan, Heba M. M., Aladl, Hossam Aladl Aladl, Ayaz, Najla O., Kurdi, Lina A. F., Jaremko, Mariusz, Alshawwa, Samar Zuhair, Saied, Essa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785777/
https://www.ncbi.nlm.nih.gov/pubmed/36559028
http://dx.doi.org/10.3390/ph15121576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785777/
https://www.ncbi.nlm.nih.gov/pubmed/36559028
http://dx.doi.org/10.3390/ph15121576

Ejemplares similares